Login / Signup

A case of postpsychotic depression improved by switching antipsychotic monotherapy.

Yoshiyo OguchiAtsuo NakagawaHiroki Kocha
Published in: Neuropsychopharmacology reports (2022)
Postpsychotic depression has more psychic characteristics than behavioral. According to various international guidelines for the pharmacological treatment of schizophrenia, antipsychotics should be administered for depressive symptoms of schizophrenia. As evidenced in this case report, lurasidone may be a practical alternative for improving postpsychotic depression.
Keyphrases
  • depressive symptoms
  • sleep quality
  • bipolar disorder
  • case report
  • social support
  • combination therapy
  • randomized controlled trial
  • clinical trial
  • clinical practice
  • double blind
  • smoking cessation